CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The GlioDx project focuses on developing non-invasive biomarkers for early diagnosis and monitoring of glioblastoma, a severe brain cancer. It aims to utilize mRNA from tumor-educated platelets to improve personalized treatment strategies.
Glioblastoma (GBM) is a devastating primary brain cancer which affects about 230.000 people annually.
The choice for treatment depends on the subtype of GBM.
An accurate detection of tumour subtype is therefore essential for a personalised targeted treatment.
Diagnosis, classification and treatment monitoring occurs currently by radiology and repeated invasive biopsies.
There is a need for non-invasive, actionable biomarkers for early-stage diagnosis and disease monitoring.During our ERC researc…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Amsterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
